Cystic Fibrosis: The Essential Role of Pancreatic Enzyme Replacement Therapy in Patient Care
December 12, 2016•18 min
Host: John J. Russell, MD
Guest: Suzanne Michel, MPH, RD, LDN
Approximately 85-90% of patients with Cystic Fibrosis suffer from pancreatic insufficiency since birth, which significantly complicates the disease and adversely affects both quality of life and life expectancy. Join Professor Suzanne Michele, registered dietitian, as she discusses supplemental enzymes and their role in the health of persons who have CF, the barriers to adherence with pancreatic enzyme replacement therapy, and how pancreatic enzyme replacement therapy is dosed in patients with CF.